Bill text replaced
This bill's text was replaced via an amendment in the nature of a substitute. Some metadata (subjects, policy area, committees) may reflect the original bill and not the current text.
Summary
The Protect Infant Formula from Contamination Act would establish faster reporting requirements for infant formula manufacturers when they discover potential safety issues. Currently, manufacturers only must report contamination after formula leaves their control. This bill would require them to notify the FDA within one business day if formula they processed may lack required nutrients or be adulterated or misbranded, and immediately report any test results showing dangerous microorganisms like salmonella. The FDA would be required to respond within one business day to begin investigating and discussing corrective actions with manufacturers.
Within 90 days of receiving a contamination report, the FDA must determine whether the manufacturer is taking appropriate corrective action. Additionally, the bill would require the FDA to periodically report on the infant formula supply chain and work with other federal agencies and industry stakeholders to improve formula safety and availability. If enacted, these changes would create a faster warning system for potentially dangerous infant formula, giving parents and healthcare providers quicker notice of safety concerns and allowing for faster removal of contaminated products from the market.
The bill has been approved by the Senate Health, Education, Labor, and Pensions Committee and is eligible for a floor vote, though it has not yet passed the full Senate or become law.
AI-generated summary
Lifecycle of the Bill
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 15, 2026
HearingSenateMeeting
Jan 15, 2026 · 15:00
Business meeting to consider S.1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, S.921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, S.2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, and S.272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements.
Summary
The Senate Committee on Health, Education, Labor, and Pensions held a business meeting on January 15, 2026, to consider four separate bills addressing different public health and safety concerns. The bills under consideration were S. 272, the Protect Infant Formula from Contamination Act, which would require testing of infant formula for microorganisms and toxic elements; S. 921, Tyler's Law, which would direct the Secretary of Health and Human Services to issue guidance on fentanyl testing in hospital emergency departments for overdose patients; S. 1157, the Women and Lung Cancer Research and Preventive Services Act of 2025, which would direct a review of lung cancer research status in women and underserved populations; and S. 2169, the Rural Hospital Cybersecurity Enhancement Act, which would require development of a comprehensive cybersecurity workforce development strategy for rural hospitals. As a business meeting rather than a hearing with witnesses, this session focused on committee consideration of the bills rather than testimony from outside parties. No witnesses were listed for this meeting, indicating the committee proceeded with its own deliberations on the proposed legislation. A business meeting of this type represents an early procedural step in the legislative process. The committee's consideration of these bills does not guarantee they will advance further. The next steps would depend on committee votes and decisions regarding whether to report the bills favorably to the full Senate for consideration.
Video
Watch videoCommittee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 15, 2026
HearingSenateMeeting
Jan 15, 2026 · 15:00
Business meeting to consider S.1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, S.921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, S.2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, and S.272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements.
Summary
The Senate Committee on Health, Education, Labor, and Pensions held a business meeting on January 15, 2026, to consider four separate bills addressing different public health and safety concerns. The bills under consideration were S. 272, the Protect Infant Formula from Contamination Act, which would require testing of infant formula for microorganisms and toxic elements; S. 921, Tyler's Law, which would direct the Secretary of Health and Human Services to issue guidance on fentanyl testing in hospital emergency departments for overdose patients; S. 1157, the Women and Lung Cancer Research and Preventive Services Act of 2025, which would direct a review of lung cancer research status in women and underserved populations; and S. 2169, the Rural Hospital Cybersecurity Enhancement Act, which would require development of a comprehensive cybersecurity workforce development strategy for rural hospitals. As a business meeting rather than a hearing with witnesses, this session focused on committee consideration of the bills rather than testimony from outside parties. No witnesses were listed for this meeting, indicating the committee proceeded with its own deliberations on the proposed legislation. A business meeting of this type represents an early procedural step in the legislative process. The committee's consideration of these bills does not guarantee they will advance further. The next steps would depend on committee votes and decisions regarding whether to report the bills favorably to the full Senate for consideration.
Video
Watch videoCommittee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Jan 28, 2026
Congress
119th Congress
Introduced
Jan 28, 2025
